Acceptance factors of telemedicine in times of COVID-19: Case Argentina
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Schlottke, Jorge AnibalAlvarez-Risco, Aldo
Bertiche, Ezequiel Leandro
López, Rocío Belén
Torletti, Carla Vanesa
del Hoyo, Facundo Yamil
Del-Aguila-Arcentales, Shyla
Mejia, Christian R.
Rojas-Osorio, Mercedes
Davies, Neal M.
Yáñez, Jaime A.
Issue Date
2024-01-01Keywords
ArgentinaCOVID-19
facilitators to use
pandemic
perceived to use
perceived usefulness
resistance to use
social influence
telehealth
telemedicine
Metadata
Show full item recordPublisher
Pensoft PublishersJournal
PharmaciaDOI
10.3897/PHARMACIA.71.E113509Abstract
We performed an analytical, cross-sectional study of 285 consumers to assess the influence of social influence, resistance to use, facilitators to use, perceived ease of use and perceived usefulness of telemedicine on the intention to use telemedicine of citizens of Argentina in times of the pandemic by COVID-19. The proposed research model was analyzed using partial least square structural equation modeling (PLS-SEM). Perceived ease of use had a positive effect (0.624) on perceived usefulness; facilitating conditions had a positive effect (0.476) on usage intention; perceived risk (-0.062) and social influence (0.072) did not have an effect on usage intention. Bootstrapping showed that the beta coefficients were statistically significant. The outcomes may provide ideas to healthcare managers to know what an expectation about telemedicine is and develop new services directed to patients. Copyright Schlottke JA et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/openAccessLanguage
engISSN
04280296ae974a485f413a2113503eed53cd6c53
10.3897/PHARMACIA.71.E113509
Scopus Count
Collections